Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
(Decitabine + tetrahydrouridine) by Novo Nordisk for Beta Thalassaemia: Likelihood of Approval
(Decitabine + tetrahydrouridine) is under clinical development by Novo Nordisk and currently in Phase I for Beta Thalassaemia. According to...
Data Insights
(Decitabine + tetrahydrouridine) by Epidestiny for Melanoma: Likelihood of Approval
(Decitabine + tetrahydrouridine) is under clinical development by Epidestiny and currently in Phase I for Melanoma. According to GlobalData, Phase...